 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The Board of Directors of Medicamen Biotech Ltd at their meeting held today has allotted the 324000 (Three Lakhs Twenty Four Thousand only) Equity Shares, at a price of Rs.618/- per share including premium of Rs.608/- each ranking pari passu with the existing equity share holders of the Company.
Shares of MEDICAMEN BIOTECH LTD. was last trading in BSE at Rs.739.8 as compared to the previous close of Rs. 744.8. The total number of shares traded during the day was 10238 in over 173 trades.
The stock hit an intraday high of Rs. 759.9 and intraday low of 725.1. The net turnover during the day was Rs. 7588307.